Ice Miller partner TaeSoo Sean Kim will be participating in a panel discussion at the 2025 Korea Drug Development Fund CPG Symposium.

Click here to see the agenda.

Program Description:

The session will focus on Legal Issues (Regulatory, Trends, etc.), a cross-border dialogue on evolving legal and BD practices in Korea, China, and the United States.

Building on the keywords we circulated, we hope this panel can bring out perspectives on:

• The importance of collaboration between BD and legal in global drug development deals;
• Country-specific approaches and regulatory frameworks, and how they influence negotiation, licensing, and M&A strategy, and;
• Practical insights for Korean biotech companies navigating global partnerships.